ARYANA CHAN: Open Payments
NPI 1891234944 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,297 in 54 payments from 7 companies in 2025. Trend: 2023 $231 · 2024 $463 · 2025 $1,297
Food & beverage: $1,297
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 23 | $341 |
| Gilead Sciences, Inc. | 13 | $254 |
| Ipsen Biopharmaceuticals, Inc | 7 | $229 |
| Madrigal Pharmaceuticals | 3 | $174 |
| Mirum Pharmaceuticals, Inc. | 2 | $163 |
| Intercept Pharmaceuticals, Inc. | 4 | $88 |
| ORPHALAN INC | 2 | $49 |
Products named: XIFAXAN, IQIRVO, REZDIFFRA, Livmarli, OCALIVA, CUVRIOR.
Industry payments across NY — which companies pay providers there.
